CatalystWireBeta

UK small-cap RNS · 24 Sep 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies
  1. 16:41
    Director/PDMR Shareholding Director dealing
  2. 14:41
    2026 Interim Results Results
    Interim Results for the period ended 30 June 2026
    Activist campaign first since Oct 2023 +0.0% on the day
  3. 14:39
    Evoke EVOK £190m
    Holding(s) in Company Holding
  4. 14:35
    Evoke EVOK £190m
    Holding(s) in Company Holding
  5. 12:33
    Holding(s) in Company Holding
  6. 12:20
    Half-year Results Results
    Interim results for H1 2026 mostly recap the KSK sale completing and the dividend already announced; no new trading or financial guidance, and the future centres on Beutong.
    Project milestones +6.0% on the day
    Moved: Cash distribution of sale proceeds: US$93.0m special dividend approved → Dividend declared, payment pending · Beutong Project: Now principal remaining asset; options under evaluation → Options under evaluation, no plan yet
  7. 12:00
    Disclosure under Rule 2.10(a)
    The 'agreed' reading is stale: Union Jack's new board rejects Reabold's all-share offer, and more holders (now 24.39%) say they will not accept, making the 75% acceptance condition harder to meet.
    Large acquisition / reverse takeover 5 acquisitions in 3 months – usually less than 1 +0.0% on the day
    Moved: Possible all-share offer for Union Jack: Declared final; rejected by Union Jack board → Final offer, rejected by board; opposition grows
  8. 10:30
    LSE market opening ceremony
    Shaires Holdings Ltd CEO, Vivek ‘Vick’ Seth, opened the day’s trading at the London Stock Exchange this morning.
    Dilutive fundraise −3.5% on the day
  9. 10:23
    Trading Update Trading update
    Second FY27 profit increase this year: adjusted PBT guidance goes to about £5.0m from £4.2m consensus on cost savings, with revenue unchanged. This returns profit to FY25 levels after a weak FY26.
    Upgrade / downgrade cycle ahead of expectationsoutlook positive, raised +7.5% on the day
    Moved: FY26 guidance delivery: FY27 profit guidance raised to £5.0m → FY27 profit guidance raised again to £5.0m · Brave Bison strategic stake: Offer period; profit forecasts published under Rule 28.1 → Offer period; forecasts reported under Rule 28.1
  10. 09:42
    Half-year Results Results
    These are H1 results, not a new warning. They show a £4.9m loss against £3.4m a year earlier, £1.2m of impairments, and only £0.2m cash at 30 June before the July raise.
    Turnaround plan with targets £7.3m · 63% of mcapoutlook mixed +0.0% on the day
    Moved: Liquidity and funding shortfall: Fundraise raised £7.3m; conditional part awaits vote → Fundraise completed 20 July 2026 (closed) · IP monetisation and strategic alternatives: Funding the capital-light licensing model → Restructuring complete; executing licensing model · MFE220 1MW testing and on-site operation: Unit non-operational; three possible causes under investigation → Independent report overdue; unit still idle
  11. 07:00
    Unaudited interim results for the six months ended 30 June 2026 Results
    Interims show on-site progress and a financed debt leg, but cash outside escrow is only £12.0m and the loss widened to £5.5m on 13.5% bond and 13% bridge interest. Escrow release still needs a US$161m equity raise.
    Project milestones outlook positive −0.5% on the day
    Moved: South Crofty development and financing: Bond issued; equity raise and FID pending; operations lead hired → Bond escrowed; equity raise and FID pending
  12. 07:00
    Drilling Results Results
    Porphyry Indicators Confirmed at Blue Rose: 23m at 0.63% Cu incl.
    Project milestones outlook positive +0.0% on the day
    Moved: Manna Hill Blue Rose drilling: Option exercised; four diamond holes done, assays pending → Two of four diamond holes reported; RC follow-up begun
  13. 07:00
    £350k Contract Win and Funding Update
    A second PSR contract with a UK Government client, backed by a formal purchase order, shows the framework converting into contracted revenue and lifts FY27 visibility to over £9.1m. The contract is small against the £4.0m selection.
    Transformational contract / build-out £0.3m · 8% of mcapoutlook positive3 new orders in 3 months – usually less than 1 +8.1% on the day
    Moved: Post-SDR contract and framework pipeline: Selected; purchase order awaited → Second PSR contract won; £4.0m award still pending · Working capital and funding: Standby debt facility under evaluation → No plc equity raise; debt facility still considered · Procure X marketplace build-out: Investment-stage; funding tied to delivery → Any funding to go through SME Procure Ltd subsidiary
  14. 07:00
    2A Executed, US$1.75m Triggered & Board Changes
    Paul Dulieu, an NED who has worked with Jennings since April, becomes CEO from 1 October 2026 and Jennings stays as an Executive Director. This ends the interim arrangement and keeps continuity as SAI-funded 2A development starts.
    New CEO / reset outlook positive −5.6% on the day
    Moved: 2A Mining Right approval: Right granted; execution and registration pending → Mining Right executed 23 Sep 2026 (closed) · HMS and diamond capacity expansion: SAI equipment shipping; commercial production targeted Q1 2027 → 2A executed; SAI preparing development · new: CEO transition to Paul Dulieu – Announced; effective 1 October 2026
  15. 07:00
    Capital Markets Event
    Sets out the Transform, Grow, Optimise plan with five-year targets (c.50% gross margin, mid-20s operating margin by FY31) and a payout of at least 75% of free cash flow, after a weak FY26 and the China impairment.
    Turnaround plan with targets £250.0m · 32% of mcapoutlook positivefirst since Oct 2023 −10.4% on the day
    Moved: CEO succession: Interim CFO in post; permanent CFO search continues → Strategy delivered; CFO search continues · Profit Improvement Plan: Headcount cut done; early savings in Q4 → Folded into five-year Optimise plan
  16. 07:00
    High-grade Limestone Confirmed at Wapouzé Project
    Maiden Wapouzé drilling found marble in every hole, with high CaO and low MgO suited to cement and possibly chemical lime. It supports a cement partner and royalty income to fund gold work.
    Project milestones outlook positive3 signals in 3 months – usually less than 1 +3.3% on the day
    Moved: new: Wapouzé limestone project – Drilling results in; ESIA underway
  17. 07:00
    Result of WRAP Retail Offer Fundraise
    Sunda Energy plc (AIM: SNDA), the AIM-quoted exploration and appraisal company focused on hydrocarbon assets in the Asia-Pacific region, is pleased to confirm, further to the announcement made at 7.01 a.m. on 22 September 2026 (the "Retail Offer …
    Dilutive fundraise −1.6% on the day
  18. 07:00
    MoU with Neo Performance Materials
    Neo becomes SX technical partner for Phalaborwa and gets offtake of 40% of NdPr and 65% of SEG+, which completes the process definition. But it is only an MoU, and the DFS slips to H1 2027.
    Project milestones outlook mixedfirst since Oct 2023 −5.3% on the day
    Moved: Phalaborwa DFS and financing: DFS 75% in engineering; SX optimisation underway → Neo MoU signed; PFS added; DFS now H1 2027
  19. 07:00
    Half-year Results Results
    A further £40m cut to FY26 profit as partner deals are pulled for renegotiation, plus c.£470m of exit charges. Underlying APBT of c.£165m is below the £200m consensus held in July.
    Turnaround plan with targets £40.0m · 5% of mcapoutlook negative, loweredfirst in 1 year −3.1% on the day
    Moved: Return £1bn to shareholders over three years via ordinary and special distributi: changed → missed – The £1bn three-year return is effectively abandoned; distributions will only be reconsidered after deleveraging. · Achieve 40% ROCE and £800m adjusted operating profit in the medium term: pending → changed – The medium-term target is replaced by lower five-year goals: ROCE above 30% and 12% operating margin by FY31. · Achieve 12%+ operating margin and 5-8% annual revenue growth in the medium term: pending → changed – The growth ambition is replaced by shrinking to about 12,000 completions a year, with the 12% margin pushed to FY31.
  20. 07:00
    Trading Update Trading update
    Adjusted profit before tax for 5M FY27 significantly higher than prior year
    Stake building towards control outlook positive, raised +7.5% on the day
    Moved: FY26 guidance delivery: 5M FY27 ahead of prior year; consensus held → FY27 profit guidance raised to £5.0m · Brave Bison strategic stake: Shareholder-support statements withdrawn at Takeover Panel's request → Offer period; profit forecasts published under Rule 28.1
  21. 07:00
    2026 half year results ahead of expectations Results
    Guidance moves from 'at least in line' (June) to full-year results 'ahead of expectations', a formal step up after H1 revenue grew 18%, though H1 EBITDA fell to $3.2m from $4.2m.
    Upgrade / downgrade cycle ahead of expectationsoutlook positive, raisedfirst in 6 months −13.3% on the day
    Moved: 2026 game release pipeline: Wishlists climbing; some releases delayed, schedule flexible → H1 launches strong; more releases follow
  22. 07:00
    Final Results Results
    Full-year results match the 23 July trading update (EBITDA £141.5m, LFL +2.1%) and FY27 is guided in line, so no surprise; profit before tax dipped slightly on higher D&A and CMA costs.
    New CEO / reset in lineoutlook positive3 business updates in 3 months – usually less than 1 −6.2% on the day
    Moved: Australia acquisition programme: Six deals in FY26; two more exchanged → FY27 deals completing; UK M&A restarts · UK CMA veterinary market process: Final Decision out; compliance under way → Final remedies order published 22 Sep 2026 (closed) · CEO succession: Search ongoing, no appointment yet → Search ongoing, no appointment yet
  23. 07:00
    Half-Year Report Announcement
    H1 swings to a $24m profit from a $6m loss as Egypt revenue rises to $100m on a $89.5/bbl oil price, though WI production slipped from 20,342 boepd to 19,337.
    Upgrade / downgrade cycle ahead of expectationsoutlook positivefirst in 6 months +1.8% on the day
    Moved: DNO offer for the company: Revised all-cash terms recommended; Scheme Document due → Both firm offers described as ongoing · Modernised concession agreement ratification: Ratified; ministerial signature still pending → Signed 19 May 2026 and effective (closed) · EGPC receivables collection: Receivables at $86m after $217m collected → Receivables $92m, up from $86m
  24. 07:00
    Scancell completes up to US$25m in debt financing
    Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
    Project milestones outlook positive −1.0% on the day
    Moved: iSCIB1+ melanoma registration path: UK MHRA CTA granted; FDA IND cleared → BlackRock loan signed; EGM approval pending
  25. 07:00
    2026 Pre-Close Trading Update Trading update
    FY26 adjusted PBT of £22-23m lands in the top half of the £18-25m range reinstated in May after the Middle East suspension, and FY27 guidance of £28-35m implies growth.
    Upgrade / downgrade cycle in lineoutlook positivefirst in 2 year +7.2% on the day
    Moved: Complete £25m buyback by 31 March 2026.: pending → delivered – Company states the three buyback programmes over two years are complete or in progress, which suggests the £25m buyback was completed, though it gives no explicit date or amount. · Share buyback programme: Launched, up to £10m, running → c.60% complete · Middle East conflict demand slowdown: Guidance reinstated lower; demand stabilised, still subdued → demand recovered; conflict still a watch item
  26. 07:00
    Half-year Results Results
    Record first-half revenue and profitability; continued strong growth in unit shipments
    Upgrade / downgrade cycle ahead of expectationsfirst in 1 year +19.6% on the day
  27. 07:00
    ASOS ASC £524m
    Pre-close Trading Update Trading update
    After repeatedly only confirming the £150-180m EBITDA range, ASOS now expects gross margin above 48-50% and EBITDA above the midpoint, with GMV back in growth in Q4. This is the first real upgrade of the turnaround.
    Upgrade / downgrade cycle ahead of expectationsoutlook positive, raised +13.7% on the day
    Moved: Multi-year turnaround: Balance sheet repair continues alongside GMV recovery → GMV back in growth in Q4; guidance raised

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note